Research Advances of m6A RNA Methylation in Non-small Cell Lung Cancer
N6-methyladenosine is one of the most prevalent mRNA modification in eukaryotes. The regulation of this pervasive mark is a dynamic and reversible process. m6A RNA methylation is catalyzed by m6A writers, removed by m6A erasers and recognized by m6A readers, thereby regulating multiple RNA processes...
Main Authors: | Hongli PAN, Xuebing LI, Chen CHEN, Yaguang FAN, Qinghua ZHOU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2020-11-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.35 |
Similar Items
-
The emerging roles of N6-methyladenosine RNA methylation in human cancers
by: Huafei Shen, et al.
Published: (2020-06-01) -
Recent Advances in Identification of RNA Modifications
by: Wei Chen, et al.
Published: (2016-12-01) -
Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer
by: Fangchao Zheng, et al.
Published: (2021-04-01) -
m6A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma
by: Hongbo Wang, et al.
Published: (2021-02-01) -
N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications
by: Jiahui Luo, et al.
Published: (2021-06-01)